Drug Approvals

JOURNAVX(suzetrigine): FDA Approves  New Treatment for Acute Pain

JOURNAVX(suzetrigine): FDA Approves New Treatment for Acute Pain

What is it prescribed for? JOURNAVX is prescribed for the treatment of moderate to severe short-term (acute) pain in adults​. It was approved on January 30th 2025 What is the name of the drug and what does it do? The brand name is JOURNAVX (pronounced "JOR-na-vix"), and the generic name is suzetrigine. JOURNAVX is used to relieve acute pain that ranges from moderate...

ZAYNICH™: A New FDA-Approved Treatment for Patients With Advanced Cancer

ZAYNICH™: A New FDA-Approved Treatment for Patients With Advanced Cancer

What is it prescribed for? ZAYNICH is a medication used to treat adults with advanced cancer that has progressed after prior treatments. It is typically used in patients whose cancer has specific features identified through testing and who have limited remaining treatment options. Advanced cancers can become resistant to standard therapies over time, making them...

BAXFENDY™: A New FDA-Approved Treatment Option for High Blood Pressure

BAXFENDY™: A New FDA-Approved Treatment Option for High Blood Pressure

What is it prescribed for? BAXFENDY is prescribed for adults with high blood pressure (hypertension). High blood pressure is a common condition that increases the risk of heart attack, stroke, heart failure, and kidney disease if left untreated. Many patients need more than one medication to control their blood pressure properly. BAXFENDY combines two medicines into...